Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
392 result(s) found, displaying 251 to 275
-
Scheduling submissionsPublic submissions on matters referred to the November 2019 scheduling meetings, and received during the interim consultation period
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend the Poisons Standard
-
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
Meeting statementsThe TGACC meeting was held on 20 Feb 2020, a communique has been published
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2020
-
Corporate reportsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 27 November 2019
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 26 July 2019
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)Final decisions to amend the Poisons Standard for substances referred to ACMS #27, ACCS #25, Joint ACMS-ACCS #22 (June 2019) and delegate-only decisions.
-
Meeting statementsCommunique from the fourth meeting of the TGACC
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Scheduling submissionsPublic submissions in response to the June 2019 ACMS/ACCS/Joint meetings
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 10 October 2019
-
Meeting statementsAdvisory Committee on Medicines
-
Scheduling decisions (final)Notice of final decisions on amendments to the Poison Standard in relation to substances considered at ACMS #26, ACCS #24, Joint ACMS-ACCS #21 (March 2019) and delegate only decisions.
-
Scheduling submissionsPublic submissions in response to the March 2019 ACMS/ACCS/Joint interim decision
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement